Peritoneal Carcinomatosis: Principles of Management

  • Paul H. Sugarbaker

Part of the Cancer Treatment and Research book series (CTAR, volume 82)

Table of contents

  1. Front Matter
    Pages i-xix
  2. General Principles

    1. Hedda H. van Ravenswaay Claasen, Alexander M. M. Eggermont
      Pages 13-40
    2. Paul H. Sugarbaker, O. Anthony Stuart, Joan Vidal-Jove, Ann Marie Pessagno, Ernst A. DeBruijn
      Pages 41-52
    3. Pierre Jacquet, Paul H. Sugarbaker
      Pages 53-63
    4. Tessa A. Sugarbaker, David Chang, Patricia Koslowe, Paul H. Sugarbaker
      Pages 65-77
    5. Karl H. Link, U. Butzer, J. Pillasch, G. Hepp, H. G. Beger
      Pages 101-114
    6. Masataka Shimotsuma, Morio Shirasu, Akeo Hagiwara, Toshio Takahashi
      Pages 147-154
    7. Paul H. Sugarbaker, Andrew M. Averbach
      Pages 163-191
  3. Techniques

    1. Schlomo Schneebaum, Mark W. Arnold, Alfred E. Staubus, Edward W. Martin Jr.
      Pages 193-209
    2. Paul H. Sugarbaker
      Pages 235-253
    3. Ann G. Archer, Paul H. Sugarbaker, James S. Jelinek
      Pages 263-288
    4. Andrew M. Averbach, Paul H. Sugarbaker
      Pages 289-309
    5. Susan K. White, Arvil D. Stephens, Barbara Dowjat, Paul H. Sugarbaker
      Pages 311-316

About this book

Introduction

Paul Sugarbaker and his colleagues have persevered in the study and treat­ ment of peritoneal carcinomatosis. The peritoneal cavity has many unique and incompletely appreciated properties. These properties, coupled with the biologic behavior of many cancers, results in the seeding and growth of these cancers on the peritoneum. Many of these cancers remain localized to the peritoneum only, never metastasizing to other sites. One possible reason for this may be the obstruction of the afferent lymphatics on the undersurface of the diaphragm. The mucopolysaccharides produced by many of these neoplasma are probably viscous enough to obstruct these lymphatics, leading to the syndrome of pseudomyxoma peritonei. Many of the neoplasms taking residence on the peritoneum have extremely long cell-cycle times and are resistant to radiotherapy and many chemotherapeutic agents. How­ ever, much can be done for these patients - resection of primary cancers, omentectomies to reduce ascites formation, management of recurrent ascites, management of intestinal obstruction, nutritional care, and, hopefully, intraperitoneal chemotherapy. We have reviewed many of these problems in the past [1-7]. Dr. Sugarbaker and his colleagues have organized the current state of knowledge and technology for continuing use. The book provides a basis for thoughtful, prospective research planning. John S. Spratt, M. D. , F. A. C. S. Professor of Surgery The James Graham Brown Cancer Center University of Louisville Louisville, Kentucky References 1. Long RTL, Spratt JS, Dowling E.

Keywords

Staging carcinoma cell immunotherapy lymphocytes metastasis ovarian cancer radiology surgery tumor

Editors and affiliations

  • Paul H. Sugarbaker
    • 1
  1. 1.Washington Cancer InstituteUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4613-1247-5
  • Copyright Information Springer-Verlag US 1996
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4612-8531-1
  • Online ISBN 978-1-4613-1247-5
  • Series Print ISSN 0927-3042
  • About this book